Comparative studies of the bactericidal, morphological and postantibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 4, 1997, Pages 471-476

  Watanabe, T ^a,b   Ohashi, K ^a   Matsui, K ^a   Kubota, T ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HABEKACIN; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PSEUDOMONAS AERUGINOSA;

EID: 0030911862     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.4.471     Document Type: Article

References (30)

1. Jevons, M. P. (1961). "Celbenin"-resistant staphylococci. British Medical Journal i, 124-5.
2. Knox, R. (1961). "Celbenin"-resistant staphylococci. British Medical Journal i, 126.
3. McDonald, P. J. (1982). Methicillin-resistant staphylococci. Medical Journal of Australia i, 445-6.
4. Crossley, K., Loesch, D., Landesman, B., Mead, K., Chem, M. & Strate, R. (1979). An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. Journal of Infectious Diseases 139, 273-9.
5. Oguri, T. (1992). Incidence and antimicrobial susceptibility of clinical isolates of MRSA from 1988 to 1990, from the results of 26 clinical laboratories in Tokyo and the surrounding area. Nippon Rinshyo 50, 952-60.
6. Aldridge, K. E., Gelfand, M. S., Schiro, D. D. & Barg, N. L. (1992). The rapid emergence of fluoroquinolone-methicillin-resistant Staphyiococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents. Diagnostic Microbiology and Infectious Disease 15, 601-8.
7. Matsumoto, K., Inamatsu, T., Watanabe, A., Akiyama, H., Shimoe, K., Iwai, S. et al, (1993). Measures of infections by MRSA and its result. Antibiotics and Chemotherapy 9, 1454-95.
8. Okamoto, R., lyobe, S. & Mitsuhoshi, S. (1986). Antibacterial activity of HBK. Chemotherapy (Tokyo) 34, Suppl. 1, 1-10.
9. Goto, S., Ogawa, M., Tsuji, A., Miyazakl, S., Kaneko, K. & Kuwahara, S. (1986). Antibacterial activity of HBK, a new derivative of dibekacin. Chemotherapy (Tokyo) 34, Suppl. 1, 11-32.
10. Matsuhashi, Y. & Yamamoto, H. (1988). The enzymatic mechanisms of resistance to aminoglycoside antibiotics in methicillincephem-resistant Staphyiococcus aureus. Japanese Journal of Antibiotics 41, 523-9.
11. Yamashita, N., Ubukata, K., Noguchi, R., Gotoh, A., Matsushita, M. & Konno, M. (1986). Antibacterial activity of HBK against staphylococci resistant to aminoglycosides. Chemotherapy (Tokyo) 34, Suppl. 1, 33-40.
12. Goto, S., Jo, K., Kawakita, T., Kosakai, N., Mitsuhashi, S., Nishino, T. et al, (1981). Determination method of minimum inhibitory concentrations. Chemotherapy (Tokyo) 29, 76-9.
13. Tanaka, N., Matsunaga, K., Hirata, A., Matsuhisa, Y. & Nishimura, T. (1983). Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic. Antimicrobial Agents and Chemotherapy 24, 797-802.
14. Tanaka, N., Matsunaga, K., Yamaki, H. & Nishimura, T. (1984). Inhibition of initiation of DMA synthesis by aminoglycoside antibiotics. Biochemical and Biophysical Research Communications 122, 460-5.
15. Tanaka, N. (1982). Mechanism of action of aminoglycoside antibiotics. In Aminoglycoside Antibiotics (Umezawa, H. & Hopper, I. R., Eds), pp. 221-66. Springer-Verlag, Berlin.
16. Watanakunakorn, C. (1981). The antibacterial action of vancomycin. Reviews of Infectious Diseases 3, Suppl., S210-5.
17. Nagarajan, R. (1991). Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrobial Agents and Chemotherapy 35, 605-9.
18. Anderson, J. S., Matsuhashi, M., Haskin, M. A. & Strominger, J. L. (1983). Llpld-phosphoacetylmuramyl-pentapeptlde and lipidphosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis. Proceedings of the National Academy of Sciences of the United States of America 53, 881-9.
19. Perkins, H. R. (1969). Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. Biochemical Journal 111, 195-205.
20. Hasegawa, H. (1993). Evaluation of the dosing regimen of vancomycin for methicillin-resistant Staphylococcus aureus infections: In vitro experimental study on doses and infusion durations. Chemotherapy (Tokyo) 41, 329-38.
21. Ishii, T., Takayama, Y., Takase, Y. & Orikasa, Y. (1994). Antibacteriological activities of arbekacin and vancomycin against strains of MRSA. Japanese Journal of Antibiotics 47, 647-54.
22. McDonald, P. J., Craig, W. A. & Kunin, C. M. (1977). Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. Journal of Infectious Diseases 135, 217-23.
23. Vogelman, B. S. & Craig, W. A. (1985). Postantibiotic effects. Journal of Antimicrobial Chemotherapy 15, Suppl. A, 37-46.
24. Nakao, M. & Nakazawa, S. (1973). Cell wall synthesis in Staphylococcus aureus in the presence of protein synthesis inhibitory agents, tetracycline and aminoglycoside antibiotics. Chemotherapy 22, 193-5.
25. Lorian, V. & Atkinson, B. (1976). Effects of subinhibitory concentrations of antibiotics on cross walls of coccl. Antimicrobial Agents and Chemotherapy 9, 1043-55.
26. Dubin, D. T., Hancock, R. & Davis, B. D. (1963). The sequence of some effects of streptomycin in Escherichia coli. Biochimica et Biophysica Acta 74, 476-89.
27. Matsunaga, K., Yamaki, H., Nishimura, T. & Tanaka, N. (1986). Inhibition of DNA replication initiation by aminoglycoside antibiotics. Antimicrobial Agents and Chemotherapy 30, 468-74.
28. Filice, G., Lanzarini, P., Orsolini, P., Soldini, L., Perversi, L, Carhevale, G. et al. (1990). Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure. Microbiologica 13, 231-7.
29. Hayashi, I., Inoue, M. & Hashimoto, H. (1994). Questionnaires regarding MRSA in Japan. Japanese Journal of Antibiotics 47, 606-17.
30. Muder, R. R., Brennen, C., Wagener, M. M. & Goetz, A. M. (1992). Bacteraemia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clinical Infectious Diseases14, 647-54.